Meridian Bioscience
- Company typePrivate
- Founded1981
- HeadquartersCincinnati, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Meridian Bioscience firmographics
Firmographics- Name
- Meridian Bioscience
- Legal name
- Meridian Bioscience
- Website
- https://meridianbioscience.com
- Company type
- Private
- Founded year
- 1981
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Meridian Bioscience industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industry
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
Keywords
Where Meridian Bioscience is headquartered
LocationHeadquarters
- HQ city
- Cincinnati
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Meridian Bioscience business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Molecular Reagents and Enzymes: Meridian offers molecular diagnostic reagents including qPCR master mixes, isothermal amplification reagents, NGS enzymes, and related enzymes sold to diagnostic manufacturers for incorporation into their test kits
- Antibodies and Antigens: Portfolio of over 3,000 antigens and antibodies covering more than 500 disease targets, sold to diagnostic manufacturers and assay developers
- Diagnostic Platforms and Tests: Meridian manufactures and sells diagnostic platforms including molecular (Revogene, Alethia), immunoassay (Curian, Immunocard STAT), urea breath testing (BreathID), and blood chemistry (LeadCare) systems along with associated test reagents
- Contract Manufacturing Services: Provides custom antibody and protein manufacturing services, and IVD contract manufacturing for diagnostic developers
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Meridian Bioscience product offering
Product offeringCore offering
Meridian Bioscience is a fully integrated life science company that develops, manufactures, and distributes diagnostic test kits and raw materials. The Life Science division supplies molecular reagents (qPCR/RT-qPCR master mixes, NGS enzymes, isothermal amplification reagents) and over 3,000 antigens and antibodies covering 500+ disease targets to diagnostic manufacturers. The Diagnostics division sells proprietary diagnostic platforms including Revogene, Alethia, BreathID, Curian, Immunocard, Premier, and LeadCare for clinical testing of gastrointestinal, respiratory, pediatric, and sexual health conditions.
Product overview
Meridian Bioscience is a fully integrated life science and diagnostic company operating in over 70 countries. The company offers two main divisions: Life Science and Diagnostics. The Life Science division provides molecular and immunological reagents for diagnostic manufacturers, including over 3,000 antigens and antibodies covering more than 500 disease targets, specialty qPCR/RT-qPCR master mixes, molecular enzymes, nucleotides, and NGS reagents. The Diagnostics division offers diagnostic platforms and tests including molecular platforms (Revogene and Alethia), urea breath testing platforms (BreathID Hp Lab, BreathID Smart, BreathID Hp), immunoassay platforms (Curian, Immunocard STAT, Immunocard, Premier, Tru, Merifluor), and blood chemistry platforms (LeadCare). The product portfolio covers disease areas including gastrointestinal (H. pylori, C. difficile, rotavirus, adenovirus), respiratory (COVID-19, flu, pertussis, RSV), pediatric/neonatal (CMV, Group B Strep, lead poisoning), and sexual health (chlamydia, gonorrhea, HIV, HSV, HCV). Meridian's molecular reagents include liquid ambient-stable master mixes, lyophilization-ready (Lyo-Ready) and air-dryable formulations, specimen-specific inhibitor-tolerant mixes, and NGS library preparation solutions. All molecular reagents are manufactured under ISO13485 regulations.
Differentiator
Problem solved
Functional benefit
Brands
- Meridian Bioline: Trusted brand by leading molecular companies, antibody companies, and diagnostic manufacturers worldwide for human diagnostics, environmental testing, and veterinary diagnostics.
Products and services
- Revogene A molecular diagnostic platform used for respiratory and infectious disease testing, including a viral respiratory testing panel. Designed for clinical laboratories.
- Alethia A molecular diagnostic platform with IVDR-certified assays for pertussis, GBS, CMV, malaria, chlamydia, gonorrhea, and HSV 1&2. Sold to clinical laboratories and hospitals.
- BreathID Hp Urea breath testing platform for H. pylori diagnosis, used by hospitals and clinical laboratories.
- BreathID Smart Urea breath testing platform for point-of-care H. pylori detection.
- BreathID Hp Lab Urea breath testing platform for H. pylori detection in laboratory settings.
- Curian Immunoassay diagnostic platform for clinical testing.
- Immunocard STAT Immunoassay platform for rapid diagnostic testing.
- Immunocard Immunoassay platform for diagnostic testing.
- Premier Immunoassay diagnostic platform.
- Tru Immunoassay platform for diagnostic testing.
- Merifluor Immunoassay platform for diagnostic testing.
- LeadCare Blood lead testing platform for pediatric and environmental lead poisoning screening.
- Para-Pak Sample collection and transport products for diagnostics.
- Antibodies and Antigens Portfolio Over 3,000 antigens and antibodies covering more than 500 disease targets including allergens, autoimmune markers, cancer markers, infectious disease antigens, and more. Sold to diagnostic manufacturers and assay developers.
- Liquid Ambient-Stable Master Mixes qPCR master mixes including Liquid Stable Flex DNA qPCR Mix and Liquid Stable Ready DNA qPCR Mix, providing 12+ months ambient-temperature stability for diagnostic kit manufacturers.
- Specimen-Specific Inhibitor Tolerant Master Mixes Sample-specific qPCR and RT-qPCR formulations for direct amplification from crude lysates or inhibitor-rich samples including blood, saliva, urine, stool, and tissue.
- Lyo-Ready and Air-Dryable Master Mixes Glycerol-free formulations including Lyo-Ready qPCR Mix, Air-Dryable qPCR Mix, Lyo-Ready 1-Step RT-qPCR Mix, and Lyo-Ready LAMP Mix, compatible with lyophilization and air-drying for room temperature shipping.
- Isothermal Amplification Reagents LAMP, NASBA, and other isothermal amplification reagents including Bst DNA Polymerase for point-of-care diagnostics in resource-limited regions.
- Glycerol-Free NGS Enzymes Glycerol-free enzymes for NGS library preparation enabling sequencing kits that can be shipped and stored at ambient temperature. Includes a Lyophilized NGS Library Preparation Kit with 12-month ambient stability.
- Molecular Enzymes Includes Taq DNA Polymerase, MMLV-RT reverse transcriptase, and Glycerol-Free Taq HS DNA Polymerase for PCR/qPCR and reverse transcription applications.
- Custom Antibody and Protein Manufacturing Services Custom antibody and protein manufacturing services, plus IVD contract manufacturing for diagnostic developers.
Quantifiable outcome
- 12+ months ambient temperature stability for liquid master mixes
- +1 more outcomes
Companies that use Meridian Bioscience
Customer profileSegments3 records
Ideal customer profiles1 record
Meridian Bioscience technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Meridian Bioscience partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- 4basescoreMeridian Bioscience and 4bases announced collaboration to enable rapid, globally scalable next-generation sequencing workflows. This partnership aims to advance molecular diagnostics capabilities through combined expertise in reagents and sequencing technologies.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
Meridian Bioscience competitors and assessment
Company assessmentDirect peers
- Hologic: Hologic is a molecular diagnostics company whose Panther system and assay menu compete with Meridian's Revogene and Alethia molecular diagnostic platforms in clinical laboratories for infectious disease testing.
- Bio-Rad Laboratories: Bio-Rad is a major manufacturer of molecular biology reagents, qPCR master mixes, and clinical diagnostics — directly comparable to Meridian's life science reagent and diagnostics businesses across both OEM and end-user channels.
- QIAGEN: QIAGEN is a global leader in molecular diagnostics and sample-prep reagents, directly competing with Meridian's PCR/qPCR reagents and NGS enzyme offerings and serving similar diagnostic manufacturer and laboratory customers.
- New England Biolabs (NEB): NEB is a leading developer and manufacturer of molecular biology enzymes and reagents, including polymerases, master mixes, and isothermal amplification tools — a direct competitor to Meridian's molecular reagent portfolio.
- Promega Corporation: Promega supplies molecular biology reagents, enzymes, and antibodies to life science researchers and diagnostic manufacturers, with overlapping product lines in qPCR reagents, NGS enzymes, and immunoassay components comparable to Meridian's offerings.
- Cepheid (Danaher): Cepheid's GeneXpert molecular diagnostic system competes directly with Meridian's Revogene platform in hospital and clinical lab settings for respiratory, sexual health, and infectious disease testing.
Broad incumbents
- Becton, Dickinson and Company (BD): BD is a broad incumbent in molecular diagnostics and life sciences with the BD MAX system and a large reagent portfolio, overlapping with Meridian's clinical diagnostics and OEM reagent businesses across multiple disease areas.
- Roche Diagnostics: Roche Diagnostics is the largest IVD player globally and a broad incumbent with cobas molecular systems, a comprehensive reagent portfolio, and proprietary chemistries that compete across Meridian's reagent and diagnostics segments.
- QuidelOrtho: QuidelOrtho is a broad incumbent in immunoassays and rapid diagnostics, competing with Meridian's Curian, Immunocard, and Premier immunoassay platforms and serving similar hospital and clinical laboratory customers.
Emerging players
- LGC Biosearch Technologies: LGC Biosearch Technologies is a specialty reagent provider in molecular biology, NGS, and oligonucleotides — an emerging competitor with partial overlap to Meridian's qPCR, NGS enzyme, and OEM reagent product lines.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Meridian Bioscience social profiles
Digital presenceMeridian Bioscience compliance and trust
Trust signalCompliance2 records
Meridian Bioscience financial estimates
Financial estimateRevenue estimate
Valuation estimate
Meridian Bioscience leadership team
Management profileNumber of profiles
Profiles6 records
Meridian Bioscience subsidiaries and ownership
Company hierarchySubsidiaries1 record
Meridian Bioscience funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Meridian Bioscience M&A and investment
M&A and investmentM&A5 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Meridian Bioscience
What does Meridian Bioscience do?
Meridian Bioscience is a fully integrated life science company that develops, manufactures, and distributes diagnostic test kits and raw materials. The Life Science division supplies molecular reagents (qPCR/RT-qPCR master mixes, NGS enzymes, isothermal amplification reagents) and over 3,000 antigens and antibodies covering 500+ disease targets to diagnostic manufacturers. The Diagnostics division sells proprietary diagnostic platforms including Revogene, Alethia, BreathID, Curian, Immunocard, Premier, and LeadCare for clinical testing of gastrointestinal, respiratory, pediatric, and sexual health conditions.
Is Meridian Bioscience a public or private company?
Meridian Bioscience is a private company. It is classified as private equity controlled and is currently operating.
When was Meridian Bioscience founded?
Meridian Bioscience was founded in 1981. It employs 501 to 1,000 people.
Where is Meridian Bioscience based?
Meridian Bioscience is headquartered in Cincinnati, United States, in the North America region.
How does Meridian Bioscience make money?
Four revenue lines are on record. Molecular Reagents and Enzymes are the primary driver. The others are antibodies and Antigens, diagnostic Platforms and Tests and contract Manufacturing Services.
Who are Meridian Bioscience's main competitors?
Direct peers on record are Hologic, Bio-Rad Laboratories, QIAGEN, New England Biolabs (NEB), Promega Corporation and Cepheid (Danaher). Broad incumbents are Becton, Dickinson and Company (BD), Roche Diagnostics and QuidelOrtho. LGC Biosearch Technologies is listed as an emerging player.
Does Meridian Bioscience have an API?
No public API is recorded for Meridian Bioscience.
What industry is Meridian Bioscience in?
Meridian Bioscience's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 334516 and its SIC code is 3826.